Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00140673
First received: August 31, 2005
Last updated: September 20, 2016
Last verified: September 2016